Serious adverse events of special interest following mRNA COVID-19 vaccination in randomized trials in adults-Reference-Cited by-同舟云学术

Serious adverse events of special interest following mRNA COVID-19 vaccination in randomized trials in adults

Published:2022-09 Issue:40 Volume:40 Page:5798-5805
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Fraiman Joseph,Erviti Juan,Jones Mark,Greenland Sander,Whelan Patrick,Kaplan Robert M.,Doshi Peter

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference50 articles.

1. Law B, Pim C. SO2-D2.1.3 Priority List of COVID-19 Adverse events of special interest [Internet]. 2021 Oct [cited 2022 Feb 17]. Available from: https://brightoncollaboration.us/wp-content/uploads/2021/11/SO2_D2.1.3_COVID-19_AESI-update_V1.0_Part-2_09Nov2021.pdf.

2. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine;Polack;N Engl J Med,2020

3. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine;Baden;N Engl J Med,2021

4. Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19;Sadoff;N Engl J Med,2021

5. Health Canada. Search for clinical information on drugs and medical devices [Internet]. 2019 [cited 2021 Nov 9]. Available from: https://clinical-information.canada.ca/.

Cited by 115 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of SARS-CoV-2 immunoserology and vaccination status with myocardial infarction severity and outcome;Vaccine;2024-12

2. Trust Us—We Are the (COVID-19 Misinformation) Experts: A Critical Scoping Review of Expert Meanings of “Misinformation” in the Covid Era;COVID;2024-09-10

3. How Safe Are COVID-19 Vaccines in Individuals with Immune-Mediated Inflammatory Diseases? The SUCCEED Study;Vaccines;2024-09-08

4. Incidence of hordeola and chalazia during the COVID-19 pandemic: the role of mask wear;Clinical and Experimental Optometry;2024-09-04

5. Reports of Batch-Dependent Suspected Adverse Events of the BNT162b2 mRNA COVID-19 Vaccine: Comparison of Results from Denmark and Sweden;Medicina;2024-08-19